RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 104 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $864,000 | +22.7% | 285,020 | 0.0% | 0.18% | +26.1% |
| Q3 2015 | $704,000 | -23.1% | 285,020 | 0.0% | 0.14% | -15.0% |
| Q2 2015 | $915,000 | +9.1% | 285,020 | +21.3% | 0.17% | +10.6% |
| Q1 2015 | $839,000 | +54.5% | 234,880 | +57.1% | 0.15% | +529.2% |
| Q2 2014 | $543,000 | -52.6% | 149,490 | -49.4% | 0.02% | -20.0% |
| Q1 2014 | $1,146,000 | +143.8% | 295,400 | +79.5% | 0.03% | +275.0% |
| Q4 2013 | $470,000 | – | 164,570 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |